Welcome to our dedicated page for Centene Del SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Centene Corporation filings document operating and financial disclosures for a government-focused managed care company. Form 8-K reports furnish quarterly results press releases, GAAP and adjusted EPS guidance, non-GAAP financial measure disclosures, conference-related Regulation FD updates and material-event reports tied to company performance.
Centene's proxy and governance filings cover annual meeting matters, board and executive compensation disclosures, equity awards, officer appointments and related corporate governance topics. Other filings address material agreements, forward-looking-statement disclosures and formal exhibits filed or furnished with the SEC.
Centene Corporation’s secretary and general counsel, Christopher A. Koster, reported an award of 126,925 shares of common stock at a price of $0, increasing his directly held beneficial ownership to 361,922.617 shares.
The grant consists of 50,770 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 76,155 performance stock units reported at target. The performance units can vest at 0%–200% of target on March 15, 2029 based on the company’s stock price performance over specified trading-day windows in 2025 and 2028.
The amendment also updates Koster’s holdings to remove 26,939 shares tied to performance stock units for the period ending December 31, 2025 that did not meet vesting criteria, as determined on January 26, 2026. Current ownership includes 123,574 previously granted stock units that remain subject to vesting requirements.
Centene Corporation’s secretary and general counsel, Christopher A. Koster, reported an award of 126,925 shares of common stock at a price of $0, increasing his directly held beneficial ownership to 361,922.617 shares.
The grant consists of 50,770 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 76,155 performance stock units reported at target. The performance units can vest at 0%–200% of target on March 15, 2029 based on the company’s stock price performance over specified trading-day windows in 2025 and 2028.
The amendment also updates Koster’s holdings to remove 26,939 shares tied to performance stock units for the period ending December 31, 2025 that did not meet vesting criteria, as determined on January 26, 2026. Current ownership includes 123,574 previously granted stock units that remain subject to vesting requirements.
Centene Corporation’s chief financial officer reported a new equity grant and corrected prior holdings. On 01/26/2026, the CFO acquired 173,573 shares of common stock at a price of $0, bringing beneficial ownership to 763,230.48 shares held directly.
The award includes 69,429 restricted stock units vesting in three annual installments beginning on March 15, 2027, plus 104,144 performance stock units at target that may vest on March 15, 2029, from 0% to 200% of target based on stock price performance tests. The amendment removes 67,985 performance stock units from total holdings because they did not meet vesting criteria for the performance period ending December 31, 2025, as determined by the Compensation and Talent Committee on January 26, 2026. Current ownership also includes 316,262 previously granted restricted and performance stock units subject to vesting.
Centene Corporation’s chief financial officer reported a new equity grant and corrected prior holdings. On 01/26/2026, the CFO acquired 173,573 shares of common stock at a price of $0, bringing beneficial ownership to 763,230.48 shares held directly.
The award includes 69,429 restricted stock units vesting in three annual installments beginning on March 15, 2027, plus 104,144 performance stock units at target that may vest on March 15, 2029, from 0% to 200% of target based on stock price performance tests. The amendment removes 67,985 performance stock units from total holdings because they did not meet vesting criteria for the performance period ending December 31, 2025, as determined by the Compensation and Talent Committee on January 26, 2026. Current ownership also includes 316,262 previously granted restricted and performance stock units subject to vesting.
Centene Corporation reported that its Chief Executive Officer received an equity award covering 520,720 shares of common stock at a price of $0. After this grant, the CEO beneficially owns 1,224,892 shares.
The award includes 138,859 restricted stock units vesting in three annual installments starting March 15, 2027, and 69,429 restricted stock units vesting in five annual installments starting the same date. It also includes 312,432 performance stock units at target, which can vest at 0% to 200% of this amount on March 15, 2029, based on stock price performance tests. The amendment removes 141,103 previously reported performance stock units that failed to meet vesting criteria, and ownership continues to reflect 450,895 previously granted restricted and performance stock units subject to vesting.
Centene Corporation reported that its Chief Executive Officer received an equity award covering 520,720 shares of common stock at a price of $0. After this grant, the CEO beneficially owns 1,224,892 shares.
The award includes 138,859 restricted stock units vesting in three annual installments starting March 15, 2027, and 69,429 restricted stock units vesting in five annual installments starting the same date. It also includes 312,432 performance stock units at target, which can vest at 0% to 200% of this amount on March 15, 2029, based on stock price performance tests. The amendment removes 141,103 previously reported performance stock units that failed to meet vesting criteria, and ownership continues to reflect 450,895 previously granted restricted and performance stock units subject to vesting.
Centene Corporation reported strong 2025 growth in revenue but a large accounting loss and issued 2026 guidance. Total 2025 revenues were $194.8 billion, with premium and service revenues of $174.6 billion, up 20% from 2024.
The company recorded a GAAP diluted loss per share of $(13.53), mainly from a non‑cash $6.7 billion goodwill impairment and a $513 million Magellan Health impairment. On an adjusted basis, diluted EPS was $2.08. The full‑year health benefits ratio rose to 91.9% from 88.3%, reflecting higher medical costs, while the adjusted SG&A expense ratio improved to 7.4% from 8.5%.
Cash flow provided by operations reached $5.1 billion, and cash, investments and restricted deposits totaled $38.8 billion at year end. For 2026, Centene guides to adjusted diluted EPS greater than $3.00, total revenues of $186.5–$190.5 billion, and a projected HBR of 90.9%–91.7%, implying margin recovery efforts alongside continued growth.
Centene Corporation’s Chief Operating Officer, Susan Raye Smith, received an equity award of 112,823 shares of common stock on January 26, 2026. The grant was reported at a price of $0 per share and increased her beneficial ownership to 225,289 shares.
The award consists of 45,129 restricted stock units that vest in three annual installments beginning March 15, 2027, and 67,694 performance stock units reported at target. The performance stock units are scheduled to vest on March 15, 2029, with the actual number earned ranging from 0% to 200% of the target amount, based on Centene’s stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028. Her total includes 90,117 previously granted restricted and performance stock units that remain subject to vesting requirements.
Centene Corporation granted Chief People Officer Tanya M. McNally 74,311 shares of common stock as equity compensation on January 26, 2026 at a price of $0 per share. Following this award, she beneficially owns 133,080 shares directly.
The new grant consists of 29,724 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 44,587 performance stock units reported at target. The performance stock units can vest from 0% to 200% of target on March 15, 2029 based on Centene’s stock price performance over specified trading-day periods in 2025 and 2028. Existing ownership also includes 49,340 previously granted restricted and performance stock units that remain subject to vesting.
Centene Corporation CEO Sarah London received a large equity grant reported on January 26, 2026. She was awarded 520,720 shares of Centene common stock at a grant price of $0, bringing her directly owned common stock to 1,365,995 shares.
The award includes 138,859 restricted stock units vesting in three annual installments beginning March 15, 2027, and 69,429 restricted stock units vesting in five annual installments beginning the same date. It also includes 312,432 performance stock units at target; the actual amount vesting on March 15, 2029 can range from 0% to 200% of that target based on Centene’s stock price performance over specified trading-day periods in 2025 and 2028.
Her ownership also reflects 591,998 previously granted restricted and performance stock units that remain subject to vesting. In addition, she directly holds a performance stock option for 13,449 shares at an exercise price of $81.85 per share, expiring December 15, 2031, which may become exercisable if Centene’s stock trades at or above $100 for 20 consecutive trading days after the original grant date.
Centene Corporation’s Secretary & General Counsel, Christopher Koster, reported an equity compensation grant and updated holdings. On January 26, 2026, he was awarded 126,925 shares of common stock at $0 per share, reflecting restricted stock units and performance stock units subject to future vesting.
Following this grant, Koster beneficially owns 388,861.617 shares of Centene common stock directly and 100 shares indirectly through his spouse. He also holds a performance stock option for 15,690 shares at an exercise price of $81.85 that may become exercisable if a share price hurdle is met, plus 3,015.544 phantom stock units settled in cash or other non‑company securities upon termination or an elected date.
Centene Corporation reported an equity grant to Corporate Controller & CAO Katie Casso. On January 26, 2026, she was awarded 26,036 shares of common stock at a price of $0, reflecting compensation rather than an open-market purchase.
The grant consists of 13,018 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 13,018 performance stock units that may vest on March 15, 2029, from 0% to 200% of target based on Centene’s stock price performance between late 2025 and late 2028. After this award, Casso beneficially owns 122,371 shares, including 62,561 previously granted restricted and performance stock units that remain subject to vesting.
Centene Corporation’s Chief Financial Officer, Asher Andrew Lynn, reported an equity award of 173,573 shares of common stock on January 26, 2026, at a price of $0 per share. This grant brings his directly held beneficial ownership of Centene common stock to 831,215.48 shares.
The award includes 69,429 restricted stock units that vest in three annual installments beginning March 15, 2027, and 104,144 performance stock units reported at target, which may vest on March 15, 2029 from 0% to 200% of target based on stock price performance tests. He also holds 13,449 performance stock options with a $81.85 exercise price expiring December 15, 2031, which become exercisable only if Centene’s stock trades at or above $100 for 20 consecutive trading days after the December 15, 2021 grant date.